Roivant Sciences Ltd. (ROIV)
NASDAQ: ROIV · Real-Time Price · USD
34.70
-1.08 (-3.02%)
Aug 11, 2026, 10:53 AM EDT - Market open
Roivant Sciences Stock Forecast
Stock Price Forecast
According to 12 analysts polled by S&P Global, Roivant Sciences stock has a consensus rating of "Strong Buy" and an average price target of $41.82. The average 1-year stock price forecast is 20.52% higher than the current stock price, while the lowest is $37 (+6.63%) and the highest is $50 (+44.09%).
Price Target: $41.82 (+20.52%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Roivant Sciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 10 | 10 | 10 | 10 | 9 | 9 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 13 | 13 | 13 | 12 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| J.P. Morgan | J.P. Morgan | Buy Maintains $40 | Buy | Maintains | $40 | +15.27% | Aug 10, 2026 |
| Citi | Citi | Buy Maintains $42 → $46 | Buy | Maintains | $42 → $46 | +32.56% | Aug 10, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $40 | Buy | Maintains | $40 | +15.27% | Aug 7, 2026 |
| Guggenheim | Guggenheim | Buy Maintains $36 → $42 | Buy | Maintains | $36 → $42 | +21.04% | Aug 7, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $41 | Buy | Reiterates | $41 | +18.16% | Aug 7, 2026 |
Financial Forecast
Revenue This Year
54.73M
from 8.26M
Increased by 562.54%
Revenue Next Year
404.21M
from 54.73M
Increased by 638.61%
EPS This Year
-1.58
from -1.08
EPS Next Year
-1.72
from -1.58
EPS and Forward PE are based on non-GAAP adjusted numbers.